Open access publisher BioMed Central, US, has announced that three BioMed Central journals have been accepted for tracking by Thomson Reuters and will receive Impact Factors in due course. The journals are: Cardiovascular Diabetology (Impact Factor due in June 2010); Radiation Oncology (Impact Factor due in June 2009); and World Journal of Surgical Oncology (Impact Factor due in June 2011).
Cardiovascular Diabetology and World Journal of Surigical Oncology were among some of the earlier titles launched as part of BioMed Central's independent journals programme. Launched in 2006, Radiation Oncology has rapidly grown to become an authoritative source of information on the treatment of cancer by radiation.
These journals bring to a total of 69 BioMed Central journals that are tracked by Thomson Reuters and either have or are on course to receive an Impact Factor.
